SALVARX GROUP PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
-47.06% | -.--% |
| 2019 | SalvaRx Evaluates Takeover Opportunities | CI |
| 2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SALVARX GROUP PLC | Bio Therapeutic Drugs | -.--% | -47.06% | - | - | - | 2.16M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- SALV Stock
- Charts SalvaRx Group plc
- Comparison Chart
